AgPlus diagnostics
AgPlus diagnostics www.agplusdiagnostics.com AgPlus’s platform consists of a clinical diagnostic assay test cartridge and a portable Agilis reader to deliver consistent point of care testing and rapid, quantitative diagnostic results. Assays are developed as two-step, single use tests that simply require the addition of the sample on to the cartridge. The assay is then inserted into reader for the analyte measurement and analysis to take place. The Agilis electrochemical platform is suitable for multiple market applications to enable faster and more accurate diagnosis, delivering real personalised care. AgPlus has developed more than fifteen assays on the platform for different B2B diagnostic customers using all human sample matrices. Collaboration Area: AgPlus’s business model is to work with diagnostic companies where the advantages of the Agilis platform creates competitive advantage for AgPlus’s B2B customer. Through CMEF, AgPlus is seeking to engage with substantial Chinese diagnostic companies to widen our existing successful collaboration through a joint venture in Suzhou.
Cognitant
Cognitant www.cognitant.com Cognitant is an Oxford-based business that uses immersive technology to provide people with accessible, personalised and trustworthy information about health and treatment. The company works with life science companies, patient advocacy groups, the NHS, health insurers and care providers to empower people to manage their health more effectively. Cognitant’s data-driven information prescription platform, Healthinote, saves clinician time, improves patient reported outcomes and reduces unnecessary complications across many care pathways. Collaboration Area: Connect to China partners and clients.
LIG Nanowise
LIG Nanowise www.lig-nanowise.com LIG Nanowise Ltd has pioneered the world’s first commercial microsphere lens based super-resolution optical microscope and the patented Super-resolution Microsphere Amplifying Lens (SMALTM) with up to 50 nm resolution that have broken the theoretical optical diffraction limit. The company has customers throughout the world including USA, Europe, Japan, South Korea and China for this new optical instrument. The key advantage is the ultra-high resolution that allows one to see viruses that conventional optical microscopes fail to see. The SMAL lens is compatible to most optical microscopes. Collaboration Area: Looks for sales and marketing partners in China.
Oxsight
Oxsight www.oxsightglobal.com/ OXSIGHT, as a spin out from the University of Oxford, won the top prize of “Google Impact Challenge”. Led by Professor Philip Torr-winner of the 2021 “Turing AI” prize. Its “Smart Bionics Glasses”, with good balance between Wearability, Functionality and Usability, could help patients who have "Central Vision Loss" due to diseases such as macular degeneration to re-see light. Collaboration area: OXSIGHT is preparing to establish a company in China and seek to IPO in the future. We’re looking for investor and marketing & sales partners.
Phoenix DX
Phoenix DX www.phoenixdx.co.uk Phoenix DX Ltd is a Bio-Medical R&D company focusing on in vitro diagnostic technology. The company has the world's leading microfluid techniques for nucleic acid detection. Our in-house designed, fully automatic high-sensitivity rapid pathogen detection system has won the 2020 BioNow Year Project Award. It can simultaneously detect three pathogens including new coronavirus, influenza A virus and respiratory syncytial virus within 25 minutes. The easy and simple operation system can be used without trained person which is suitable for hospitals, clinics, care home and family use. Collaboration area: Due to market demand and also as the company business plan, the company is currently • Looking for further investment. The ideally investor should have certain strength and interested in the field of in vitro diagnostics. • Looking for cooperation partners who have the ability to manufacture our prototype to meeting industrial standard which requested by UKCA, CE or FDA. • Looking for distributors who got mature sale channels and meet our other requirement.
Plasma
Plasma www.plasma-biotal.com Plasma Biotal Ltd are one of the world’s longest-standing (over 30 years) orthopaedic implant coating firms, and the UK’s leading manufacturer and supplier of synthetic bone (CAPTAL® Hydroxyapatite) and bespoke calcium phosphate materials. Our product portfolio includes HA, β-TCP, ACP and α-TCP, as well as biphasic material. All materials are available as coating powders, speciality powders and granules as required, and customized calcium phosphates are available upon request. All materials manufactured by us meet the ISO 13485 accreditation and recognised international standards and are US FDA registered. Started in 2017, Plasma Biotal India provides the SAARC nations with affordable, but international quality coatings on their doorstep, eliminating long lead times and logistical problems associated with obtaining suitable medical-grade coatings from Europe. Collaboration area: We are looking to supply our HA, ultrabrite and beta tri-calcium powders to company’s who work within the orthopaedic coatings sector (coating medical devices and implants). The application of our powders are also used in many other sectors including bone cements, cosmetic derma fillers and dentistry.
Seroxo
Seroxo seroxo.com/index.html Seroxo has developed rapid point of care test for measurement and monitoring of immune function/dysfunction. • LIT™ score is a novel prognostic predictor of mortality for ICU patients with COVID, sepsis • 10-minute rapid test only requires finger prick blood • LIT™ showed significantly faster response compared to other conventional biomarkers such as C-reactive protein • Successfully categorize sepsis patients into three levels of time-associated mortality risk • Strong IP position • Broad clinical applications and markets • Completed clinical trials validate proof of concept for use in COVID, sepsis, & cancer; other clinical studies in progress • Experienced professional team Collaboration area: The company is raising a Series A investment of $9 million. Investment from individuals, organisations or venture capital are all welcomed.
YOURmeds
YOURmeds www.yourmeds.net YOURmeds, a smart medication support solution, enables patients to take the right medicine at the right time with help from their support network of family and friends. Using mobile technology supporters and monitoring centres can ‘nudge’ the patient in real time, increasing adherence to 80% or more. Increasing adherence improves health outcomes, increases independence and provides peace of mind to family and friends. The real time data obtained knows if medication is taken early, late, if the wrong medication is taken or when too many are taken. Collaboration area: Introduction to contacts and networks that would be interested in YOURmeds including pharmacy network, care providers, healthcare professionals interested in monitoring medication adherence.
Zimmer and Peacock Ltd
Zimmer and Peacock Ltd www.zimmerpeacocktech.com Zimmer and Peacock is an ISO13485 certified contract developer and manufacturer of electrochemical biosensor and in-vitro diagnostics (IVDs). At ZP we see that sensors are a critical part of a number of Social and Commercial Revolutions, including the Internet of Things (IoT), AgTech, Sensor Web, growth in the IVD market, rapid testing in the Food and Beverage Industry and wearable biosensors for Wellness Tracking. As part of this Zimmer and Peacock provides a range of products and services including: sensors, the necessary hardware, and customer specific android and iOS applications, IP generation and scalable manufacturing. Collaboration area: Here at Zimmer and Peacock, our collaboration need is to increase trade cooperation between China and UK by connecting to China clients.